z-logo
Premium
Oral administration of Eucommia ulmoides Oliv . leaves extract protects against atherosclerosis by improving macrophage function in ApoE knockout mice
Author(s) -
HashikawaHobara Narumi,
Hashikawa Naoya,
Sugiman Nao,
Hosoo Shingo,
Hirata Tetsuya,
Yamaguchi Yasuyo,
Yamasaki Hiroo,
Kawasaki Hiromu,
Nishibe Sansei
Publication year - 2020
Publication title -
journal of food science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 150
eISSN - 1750-3841
pISSN - 0022-1147
DOI - 10.1111/1750-3841.15461
Subject(s) - eucommia ulmoides , macrophage , apolipoprotein e , knockout mouse , medicine , inflammation , cytokine , apolipoprotein b , pharmacology , immunology , endocrinology , traditional medicine , traditional chinese medicine , chemistry , biochemistry , pathology , receptor , in vitro , cholesterol , alternative medicine , disease
Eucommia leaf extract (ELE) is a traditional Chinese herbal medicine. We investigated the effect of ELE on the development of atherosclerosis and changes in peritoneal macrophage function in apolipoprotein E knockout (ApoE –/– ) mice. At 8 weeks of age, ApoE –/– mice were randomly divided into three groups that were fed a high‐fat diet blended with 0% (control), 5% or 10% ELE for a period of 7 weeks. The 10% ELE dose caused an approximately 36% reduction in atherosclerotic lesions, as estimated by oil red O staining. Real‐time PCR analysis showed that the 1‐week treatment with ELE reduced mRNA levels of Tnf‐alpha , Il‐1 , and Mif in peritoneal macrophages isolated from the ApoE –/– mice. Furthermore, a 1‐week treatment with the 10% ELE diet significantly reduced migration and adhesion functions in peritoneal macrophages. These results suggest that a 10% ELE diet reduces atherosclerotic lesions and modulates macrophage function by reducing cytokine expression. Practical Application Eucommia leaf extract (ELE) is a traditional Chinese herbal medicine that reduces atherosclerotic lesions and suppresses inflammatory cytokines expression.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here